Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- STHG, CEGE, ACUS, XDSL - OTCStockExchange.com Stock Alert.
- M2 PRESSWIRE-1 April 2008-otcstockexchange.com: STHG, CEGE, ACUS, XDSL - OTCStockExchange.com Stock AlertC1994-2008 M2 COMMUNICATIONS LTD RDATE:01042008 Rochester, NY -- OTCStockExchange.com's "Stock Watch Alert" this morning are Steadfast Holdings Group, Inc. (Pink Sheets: STHG), Cell Genesys, Inc. (Nasdaq: CEGE), Acusphere Inc....
- Research articles 2008-04-01
- Andrx Corporation Reports Financial Results for 2006 First Quarter
- FORT LAUDERDALE, Fla. -- Andrx Corporation (Nasdaq:ADRX) ("Andrx" or the "Company") today announced its financial results for the three months ended March 31, 2006 (the "2006 Quarter"), which are discussed more extensively in Andrx's Form 10-Q for the 2006 Quarter ("March 2006 10-Q") being filed today with the U.S. Securities...
- Research articles 2006-05-04
- BASF Outlines Growth Strategy In Major Markets.
- The company will focus on health and nutrition following acquisitions. BASF POSTED record sales during its fiscal second quarter, mainly because of the strong performance of its cyclical and commodity products. But because of a refocusing of ...
- Research articles 2000-08-14
Additional Resources
- Johnson & Johnson's McNeil and Takeda Announce Strategic Alliance to Market OTC Products in Japan
- TOKYO--BUSINESS WIRE--Sept. 18, 1997--Johnson & Johnson's (NYSE:JNJ) McNeil Consumer Products Company McNeil and Takeda Consumer Healthcare Company, a division of Takeda Chemical Industries, Ltd., (NIKKEI:TAKEDA), announced today an alliance to market non-prescription healthcare products in Japan.
- Research articles 1997-09-18
- Lexicon Genetics and Takeda establish collaboration to develop new drugs for high blood pressure.(Lexicon Genetics Inc.)(Takeda Pharmaceuticals)
- Lexicon Genetics, Inc. (The Woodlands, TX) and Takeda Pharmaceutical Company Limited (Osaka, Japan) announced the formation of a collaboration to develop new drugs for the treatment of high blood pressure. The alliance is designed to accelerate the development and commercialization of new drugs directed against promising...
- Research articles 2004-07-01
- Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
- CAMBRIDGE, Mass. & OSAKA, Japan -- Archemix Corp. ("Archemix") and Takeda Pharmaceutical Company Limited ("Takeda") announced today that both parties have signed a multi-year, three target agreement that focuses on the discovery, development and commercialization of first-in-class aptamer-based therapeutics. Under the agreement, Archemix will receive an upfront payment of...
- Research articles 2007-06-11
- 3M Pharmaceuticals and Takeda to Collaborate on Potential Treatment for Cervical High-Risk HPV Infection and Cervical Dysplasia
- ST. PAUL, Minn. & OSAKA, Japan -- 3M and Takeda Pharmaceutical Company Limited Takeda announced today that the two companies entered into an exclusive co-development and joint marketing agreement to collaborate on a potential topical treatment for cervical high-risk human papillomavirus HPV infection and cervical dysplasia.
- Research articles 2005-03-01
- Mitsui and Takeda form joint venture chemical company.
- The Japanese companies Mitsui Chemicals Inc and Takeda Chemical Industries Ltd are to merge their composites and chemicals businesses. The Japanese companies Mitsui Chemicals Inc and Takeda Chemical Industries Ltd are to merge their composites and chemicals businesses.
- Research articles 2001-01-01
- Sumitomo, Takeda form ag chemicals venture. (News).(Japan's largest drug manufacturer forms joint venture with Sumitomo Chemical Company Ltd.)(International Pages)(Brief Article)
- SUMITOMO CHEMICAL Company Ltd. and Takeda Chemical Industries Ltd. have formed a joint venture in agrochemicals, Sumika Takeda Agrochemical Company Ltd. The new company will be based in Tokyo and operate as a joint venture company for five years. S SUMITOMO CHEMICAL Company Ltd....
- Research articles 2002-08-05
- Mitsui, Takeda in Urethane JV.(Mitsui Chemical Co.)(Takeda Chemical Industries Ltd.)(Brief Article)
- MITSUI CHEMICALS and Takeda Chemical Industries have agreed to form a joint venture to merge their urethane chemicals and composite materials product lines. The new company, Mitsui Takeda Chemicals Inc. MTCI, will be 51 percent owned by Mitsui an MITSUI CHEMICALS and Takeda Chemical...
- Research articles 2000-10-16
- Purchase of Additional Wyeth K.K. Equity by Wyeth from Takeda Changes Control.
- MADISON, New Jersey and OSAKA, Japan, April 7 /PRNewswire/ -- Wyeth (NYSE: WYE) and Takeda Pharmaceutical Company Limited Takeda today announced that Wyeth purchased additional equity of Wyeth K.K. WKK, their Joint Venture company, giving Wyeth 70% ownership of WKK, providing full management control over the...
- Research articles 2005-04-07
- Mitsui Chemicals, Takeda Merge Polyurethanes.(Takeda Chemical Industries)(Brief Article)
- Mitsui Chemicals and Takeda Chemical Industries have agreed to merge their respective polyurethane PU raw material businesses into a 51-49 joint venture, Mitsui Takeda Chemicals MTC. The merged company will begin operating next April, subject to antitrust approval. MTC will be Asia's biggest PU raw material...
- Research articles 2000-10-04
- Sumitomo acquires Takeda's pesticides business. (Business & Finance News).(Brief Article)
- Sumitomo Chemical has agreed to acquire a majority stake in Takeda Chemical Industries' pesticides operation, and says it will later assume full ownership of the business. Analysts estimate the total purchase price at [yen]30 billion-[yen]50 billion ($259 million-$431 million). The deal is subject to antitrust approval....
- Research articles 2002-08-07
- Hitachi, Takeda Pharmaceutical to Establish Information System
- Tokyo, Oct 7, 2005 - JCN - Hitachi and Takeda Pharmaceutical jointly announced on October 3 that the two companies have basically agreed to establish a joint venture company for information system service as of September 29.
- Research articles 2005-10-07
- Sucampo Pharmaceuticals Inc. Q1 2008 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions Our first question is coming from the line of Ian Sanderson with Cowen and Company. Please proceed with your question. Ian Sanderson - Cowen and Company Thank you and good morning. Thanks for taking the question. Mariam, can you provide some additional color on Takeda's...
- Earnings calls 2008-05-26
- HTG Announces Services Agreement with Takeda Pharmaceutical Company Limited; HTG's Gene Expression Technology to Support Takeda's Pharmaceutical Research
- TUCSON, Ariz. -- HTG, Inc. today announced that Takeda Pharmaceutical Company Limited has signed an agreement for HTG's patented ArrayPlateTM technology and service support. HTG provides novel gene expression technology and services for the life sciences and pharmaceutical industries. Takeda is the largest pharmaceutical company in Japan. Under the...
- Research articles 2004-09-22
- HEY, ABBOTT! YOUR ALLY GOES IT ALONE: TAKEDA'S U.S. DRIVE STARTS HERE.
- Takeda Chemical Industries Ltd., Japan's largest drug company, is making an aggressive push into the U.S. market and using a new office here as its launching pad. Takeda Pharmaceuticals America Inc. TPA, a newly created marketing unit of the Jap Takeda Chemical Industries...
- Research articles 1999-03-01
- Pfizer Gains Presence in Diabetes Market with Takeda Deal
- ChinaBio Today submits: Pfizer (NYSE: PFE) has taken on the job of co-promoting a diabetes drug in China for Takeda Pharmaceutical Company. Actos pioglitazone HCl, an oral treatment for diabetes 2, produces over $4 billion of annual revenues for Takeda worldwide. The agreement will be in force until 2020...
- External links 2009-12-16
- Danish pharmaceutical company H Lundbeck A/S signs cooperation agreement with Japan's Takeda Pharmaceutical Company Limited
- NORDIC BUSINESS REPORT-5 September 2007-Danish pharmaceutical company H Lundbeck A/S signs cooperation agreement with Japan's Takeda Pharmaceutical Company LimitedC1994-2007 M2 COMMUNICATIONS LTD http://www.m2.com Danish pharmaceutical company H Lundbeck A/S announced on Wednesday (5 September) a strategic alliance with Japan's Takeda Pharmaceutical Company Limited. The companies will cooperate in...
- Research articles 2007-09-05
- Sales for the pharmaceutical company Takeda increased by 7% to reach 935,213 million.
- M2 PRESSWIRE-31 May 2006-Research and Markets: Sales for the pharmaceutical company Takeda increased by 7 to reach 935,213 million.C1994-2006 M2 COMMUNICATIONS LTD RDATE:02062006 Dublin: Research and Markets (http://www.researchandmarkets.com/reports/c37826) has announced the addition of the Espicom Business Intelligence Ltd report: Takeda...
- Research articles 2006-05-31
- << Previous
- page 1 of 1
- Next >>
Presented by American Express